Intra-Cellular Therapies Set for Major Presentation Event

Intra-Cellular Therapies' Upcoming Presentation at a Key Event

Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) marks an important moment in its calendar as it prepares for a noteworthy presentation. This biopharmaceutical company specializes in developing transformative therapeutics aimed at addressing central nervous system (CNS) disorders. The event is highly anticipated by investors and professionals in the healthcare community.

Overview of the Conference Details

Sharon Mates, Ph.D., the Chief Executive Officer and Chairman of Intra-Cellular Therapies, will take the stage at a prestigious healthcare conference, where she will share insights about the company's strategic approach and future directions. The presentation is scheduled for Monday, January 13, at 11:15 a.m. PT. Attendees can look forward to gaining valuable information about the company’s latest developments and projects.

How to Join the Presentation

The presentation will be accessible via a live and archived webcast, which participants can find under the "Events & Presentations" section of Intra-Cellular Therapies' investor website. It is recommended to log in early to ensure proper software installation and registration, providing attendees a smooth experience.

The Significance of Intra-Cellular Therapies

Founded based on groundbreaking Nobel prize-winning research, Intra-Cellular Therapies leverages a deep understanding of cellular mechanisms to devise innovative treatments targeting complex psychiatric and neurologic disorders. This unique intracellular approach places the company at the forefront of biopharmaceutical advancements.

Innovative Treatments for CNS Disorders

Intra-Cellular Therapies is committed to developing therapies that could profoundly impact patients' lives by addressing unmet medical needs in psychiatric and neurologic fields. The solutions being researched and developed could lead to better outcomes for individuals affected by these challenging conditions.

Contact Information for Inquiries

Intra-Cellular Therapies encourages interested parties to reach out for more information about their upcoming presentation or to learn more about their work. They provide several channels for communication:

Corporate Communications

For direct inquiries, Juan Sanchez, M.D., who serves as the Vice President of Corporate Communications and Investor Relations, can be contacted at 646-440-9333. They are committed to transparency and communication, especially with stakeholders.

Media Relations

For media-related inquiries, Cameron Radinovic from Burns McClellan, Inc. is available at 646-930-4406 or via email at cradinovic@burnsmc.com. Engaging with the media is crucial for fostering public understanding of their initiatives and mission.

Frequently Asked Questions

What is the focus of Intra-Cellular Therapies?

Intra-Cellular Therapies is dedicated to developing therapeutics for central nervous system disorders through innovative cellular research.

When is the presentation at the J.P. Morgan Healthcare Conference?

The presentation is scheduled for January 13, at 11:15 a.m. PT.

How can I access the conference presentation?

The presentation will be available via a live and archived webcast on the company's investor website.

Who is presenting on behalf of Intra-Cellular Therapies?

Sharon Mates, Ph.D., the Chief Executive Officer and Chairman, is set to deliver the presentation.

How can I get more information regarding the company?

Potential inquiries can be directed to Juan Sanchez, M.D., or Cameron Radinovic for updates and insights about Intra-Cellular Therapies.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.